Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Centene Corporation CNC Q1 2026 Earnings Preview Key Metrics Market Expectations and Peer Benchmarks TJX Companies Inc TJX A Defensive Dividend Growth Play for Volatile Market Environments Xcel Energy XEL Valuation Disparity Emerges Amid Balanced Growth Drivers and Downside Risks ORIQ Origin CEO highlights planned portfolio diversification in comments accompanying latest quarterly earnings